David G Huntsman

发表

Synthesis of diagnostic quality cancer pathology images by generative adversarial networks

Yiping Wang, Anne Mills, Ali Bashashati, 2020, The Journal of pathology.

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Marc Tischkowitz, David G Huntsman, T. Nielsen, 2007, BMC Cancer.

Fluorescence In Situ Hybridization for the Detection of t(X;18)(p11.2;q11.2) in a Synovial Sarcoma Tissue Microarray Using a Breakapart-Style Probe

Jefferson Terry, David G Huntsman, A. Gown, 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies

Frank McCormick, Basile Tessier-Cloutier, Irem Ozkan-Dagliyan, 2017, Science Signaling.

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer

Karen A Gelmon, Paul A Rejto, David G Huntsman, 2011, Modern Pathology.

Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma

Michael Peacock, C Blake Gilks, David G Huntsman, 2004, Clinical Cancer Research.

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

Fan Zhang, Yiling Lu, Gordon B Mills, 2014, BMC Cancer.

Clear cell carcinomas of the ovary and kidney: clarity through genomics

Yi Kan Wang, J. X. Ji, David G Huntsman, 2018, The Journal of pathology.

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

Rohini Rau-Murthy, Jinghui Zhang, Kenneth Offit, 2013, Nature Genetics.

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification

Samuel Leung, Christine Chow, C Blake Gilks, 2017, The journal of pathology. Clinical research.

Molecular pathology of cancer

David G Huntsman, D. Huntsman, 1997, British Journal of Cancer.

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss

Matt van de Rijn, George Coukos, Dmitry Turbin, 2009, Modern Pathology.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

Francesmary Modugno, Christine Chow, Ellen L Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.

Harvey Risch, Yian A Chen, Mads Thomassen, 2018, Cancer research.

FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Charles M Perou, Dmitry Turbin, Harikrishna Nakshatri, 2007, Clinical Cancer Research.

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Anna Adamiak, Russell Vang, C Blake Gilks, 2009, BMC Cancer.

CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer

Wonshik Han, Jonathan R Pollack, Dong-Young Noh, 2008, Molecular oncology.

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

C Blake Gilks, David G Huntsman, D. Huntsman, 2002, American journal of clinical pathology.

Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer

Wen-Lin Kuo, Gordon B Mills, Jane Fridlyand, 2007, Clinical Cancer Research.

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling

Ali Bashashati, Thomas Zeng, Stephen Yip, 2013, The Journal of pathology.

Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors

Kiran Jakate, Nataliya Melnyk, David G Huntsman, 2013, Modern Pathology.

Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study

Samuel Leung, C Blake Gilks, David G Huntsman, 2010, The American journal of surgical pathology.

Amplification of 11q13 in ovarian carcinoma

C Blake Gilks, Joe Gray, David G Huntsman, 2008, Genes, chromosomes & cancer.

Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits

Ryan D. Morin, Daniel Fornika, Jordan Davidson, 2017, Scientific Reports.

Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer

Ali Bashashati, Alexandre Bouchard-Côté, Richard A. Moore, 2016, Nature Genetics.

Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors

Steven J. M. Jones, Inanc Birol, Malachi Griffith, 2010, Genome Biology.

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Sohrab P Shah, Jiarui Ding, Janine Senz, 2012, Modern Pathology.

Evolutionary concepts in biobanking - the BC BioLibrary

Adrian Png, Samuel Aparicio, Rebecca O Barnes, 2009, Journal of Translational Medicine.

Use of mutation profiles to refine the classification of endometrial carcinomas

Thomas Zeng, Martin Hirst, Kane Tse, 2012, The Journal of pathology.